HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy
- PMID: 27588488
- PMCID: PMC5323119
- DOI: 10.18632/oncotarget.11706
HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy
Abstract
HuR is an mRNA-binding protein whose overexpression in cancer cells has been associated with poor prognosis and resistance to therapy. While reports on HuR overexpression contributing to chemoresistance exist, limited information is available on HuR and radioresistance especially in triple-negative breast cancer (TNBC).In this study we investigated the role of HuR in radiation resistance in three TNBC (MDA-MB-231, MDA-MB-468 and Hs578t) cell lines. Endogenous HuR expression was higher in TNBC cells compared to normal cells. siRNA mediated knockdown of HuR (siHuR) markedly reduced HuR mRNA and protein levels compared to scrambled siRNA (siScr) treatment. Further, siHuR treatment sensitized TNBC cells to ionizing radiation at 2 Gy compared to siScr treatment as evidenced by the significant reduction in clonogenic cell survival from 59%, 49%, and 65% in siScr-treated cells to 40%, 33%, and 46% in siHuR-treated MDA-MB-231, MDA-MB-468 and Hs578t cells, respectively. Molecular studies showed increased ROS production and inhibition of thioredoxin reductase (TrxR) in HuR knockdown cells contributed to radiosensitization. Associated with increased ROS production was evidence of increased DNA damage, demonstrated by a significant increase (p < 0.05) in γ-H2AX foci that persisted for up to 24 h in siHuR plus radiation treated cells compared to control cells. Further, comet assay revealed that HuR-silenced cells had larger and longer-lasting tails than control cells, indicating higher levels of DNA damage. In conclusion, our studies demonstrate that HuR knockdown in TNBC cells elicits oxidative stress and DNA damage resulting in radiosensitization.
Keywords: DNA repair; HuR; breast cancer; radiation; siRNA.
Conflict of interest statement
The author(s) declare no competing financial interests.
Figures







Similar articles
-
Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.Cancer Lett. 2017 May 1;393:103-112. doi: 10.1016/j.canlet.2017.02.010. Epub 2017 Feb 20. Cancer Lett. 2017. PMID: 28219770
-
Knockdown of CAVEOLIN-1 Sensitizes Human Basal-Like Triple-Negative Breast Cancer Cells to Radiation.Cell Physiol Biochem. 2017;44(2):778-791. doi: 10.1159/000485291. Epub 2017 Nov 23. Cell Physiol Biochem. 2017. PMID: 29169152
-
Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.Oncol Rep. 2017 Apr;37(4):2382-2390. doi: 10.3892/or.2017.5478. Epub 2017 Feb 28. Oncol Rep. 2017. PMID: 28260023 Free PMC article.
-
Inhibition of Caspase-2 Translation by the mRNA Binding Protein HuR: A Novel Path of Therapy Resistance in Colon Carcinoma Cells?Cells. 2019 Jul 30;8(8):797. doi: 10.3390/cells8080797. Cells. 2019. PMID: 31366165 Free PMC article. Review.
-
Enhancing radiotherapy techniques for Triple-Negative breast cancer treatment.Cancer Treat Rev. 2025 May;136:102939. doi: 10.1016/j.ctrv.2025.102939. Epub 2025 Apr 17. Cancer Treat Rev. 2025. PMID: 40286498 Review.
Cited by
-
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.Mol Cancer Ther. 2017 Aug;16(8):1470-1486. doi: 10.1158/1535-7163.MCT-17-0134. Epub 2017 Jun 1. Mol Cancer Ther. 2017. PMID: 28572169 Free PMC article.
-
Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells.Cancer Res. 2017 Aug 15;77(16):4460-4471. doi: 10.1158/0008-5472.CAN-17-0015. Epub 2017 Jun 26. Cancer Res. 2017. PMID: 28652247 Free PMC article.
-
Mechanisms of radioresistance and radiosensitization strategies for Triple Negative Breast Cancer.Transl Oncol. 2025 May;55:102351. doi: 10.1016/j.tranon.2025.102351. Epub 2025 Mar 19. Transl Oncol. 2025. PMID: 40112501 Free PMC article. Review.
-
Post-transcriptional regulation of Nrf2-mRNA by the mRNA-binding proteins HuR and AUF1.FASEB J. 2019 Dec;33(12):14636-14652. doi: 10.1096/fj.201901930R. Epub 2019 Nov 1. FASEB J. 2019. PMID: 31665914 Free PMC article.
-
RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.Theranostics. 2020 Jul 2;10(18):7974-7992. doi: 10.7150/thno.45037. eCollection 2020. Theranostics. 2020. PMID: 32724453 Free PMC article.
References
-
- Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harns JR. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008;26:2373–2378. - PubMed
-
- Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J Danish Breast Cancer Cooperative Group. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419–1426. - PubMed
-
- Goodhead DT. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol. 1994;65:7–17. - PubMed
-
- Barzilai A, Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst) 2004;3:1109–15. - PubMed
-
- Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Rad Biol. 1994;65:27–33. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous